| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 23,017 | 22,864 | 21,723 | 26,169 | | Cost of Revenue | 29,247 | 31,451 | 31,175 | 38,246 | | | Gross Profit | (6,230) | (8,587) | (9,452) | (12,077) | | | Operating Expenses | | Research Development | 4,150 | 5,053 | 5,737 | 6,314 | | Selling General and Administrative | 4,107 | 4,755 | 4,246 | 4,432 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,487) | (18,395) | (19,435) | (22,823) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 170 | (86) | 69 | (153) | | Earnings Before Interest And Taxes | (14,850) | (19,014) | (19,859) | (24,833) | | Interest Expense | 65 | 66 | 60 | 35 | | Income Before Tax | (14,915) | (19,080) | (19,919) | (24,868) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (533) | (533) | (493) | (473) | | | | Net Income From Continuing Ops | (14,915) | (19,080) | (19,919) | (23,484) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,915) | (19,080) | (19,919) | (23,484) | | Preferred Stock And Other Adjustments | (802) | (802) | (802) | (802) | | | Net Income Applicable To Common Shares | ($15,717) | ($19,882) | ($20,721) | ($24,286) |
|
0.02% Nasdaq 
0.49 (15.51%) 
Income Statement
